DE69006105T2 - Kristallines Deoxyspergualin und Verfahren zu seiner Herstellung. - Google Patents
Kristallines Deoxyspergualin und Verfahren zu seiner Herstellung.Info
- Publication number
- DE69006105T2 DE69006105T2 DE69006105T DE69006105T DE69006105T2 DE 69006105 T2 DE69006105 T2 DE 69006105T2 DE 69006105 T DE69006105 T DE 69006105T DE 69006105 T DE69006105 T DE 69006105T DE 69006105 T2 DE69006105 T2 DE 69006105T2
- Authority
- DE
- Germany
- Prior art keywords
- deoxyspergualin
- form crystals
- crystals
- powder
- hydrochloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims description 19
- 229960002706 gusperimus Drugs 0.000 title description 3
- IDINUJSAMVOPCM-INIZCTEOSA-N n-[(1s)-2-[4-(3-aminopropylamino)butylamino]-1-hydroxy-2-oxoethyl]-7-(diaminomethylideneamino)heptanamide Chemical compound NCCCNCCCCNC(=O)[C@H](O)NC(=O)CCCCCCN=C(N)N IDINUJSAMVOPCM-INIZCTEOSA-N 0.000 title description 3
- 239000013078 crystal Substances 0.000 claims description 60
- 239000000843 powder Substances 0.000 claims description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- 239000006188 syrup Substances 0.000 claims description 21
- 235000020357 syrup Nutrition 0.000 claims description 21
- 238000002425 crystallisation Methods 0.000 claims description 19
- 230000008025 crystallization Effects 0.000 claims description 19
- 238000002441 X-ray diffraction Methods 0.000 claims description 15
- AXSPHUWXYSZPBG-OKUPDQQSSA-N n-[(1s)-2-[4-(3-aminopropylamino)butylamino]-1-hydroxy-2-oxoethyl]-7-(diaminomethylideneamino)heptanamide;trihydrochloride Chemical compound Cl.Cl.Cl.NCCCNCCCCNC(=O)[C@H](O)NC(=O)CCCCCCN=C(N)N AXSPHUWXYSZPBG-OKUPDQQSSA-N 0.000 claims description 12
- 239000007900 aqueous suspension Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- AXSPHUWXYSZPBG-UHFFFAOYSA-N Gusperimus hydrochloride Chemical compound Cl.Cl.Cl.NCCCNCCCCNC(=O)C(O)NC(=O)CCCCCCN=C(N)N AXSPHUWXYSZPBG-UHFFFAOYSA-N 0.000 description 48
- 239000007864 aqueous solution Substances 0.000 description 6
- 238000001914 filtration Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 238000004455 differential thermal analysis Methods 0.000 description 4
- 229910002804 graphite Inorganic materials 0.000 description 4
- 239000010439 graphite Substances 0.000 description 4
- 239000008176 lyophilized powder Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000002411 thermogravimetry Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002076 thermal analysis method Methods 0.000 description 2
- MNKRWWHDVSPGIV-UHFFFAOYSA-N 7-(diaminomethylideneamino)heptanamide Chemical compound NC(=O)CCCCCCNC(N)=N MNKRWWHDVSPGIV-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- NZQZZKUBOTVFFS-UHFFFAOYSA-N n-[4-(3-aminopropylamino)butyl]-2-oxoacetamide Chemical compound NCCCNCCCCNC(=O)C=O NZQZZKUBOTVFFS-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13287889 | 1989-05-29 | ||
| JP13287989 | 1989-05-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69006105D1 DE69006105D1 (de) | 1994-03-03 |
| DE69006105T2 true DE69006105T2 (de) | 1994-07-07 |
Family
ID=26467336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69006105T Expired - Fee Related DE69006105T2 (de) | 1989-05-29 | 1990-05-23 | Kristallines Deoxyspergualin und Verfahren zu seiner Herstellung. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0400889B1 (cg-RX-API-DMAC7.html) |
| KR (1) | KR940005918B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1017621B (cg-RX-API-DMAC7.html) |
| AR (1) | AR247877A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU626676B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2017361C (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ261390A3 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69006105T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2062363T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HU207844B (cg-RX-API-DMAC7.html) |
| PL (1) | PL163358B1 (cg-RX-API-DMAC7.html) |
| TW (2) | TW275620B (cg-RX-API-DMAC7.html) |
| YU (1) | YU48230B (cg-RX-API-DMAC7.html) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5862152A (ja) * | 1981-10-08 | 1983-04-13 | Microbial Chem Res Found | Ｎ−〔４−（３−アミノプロピル）アミノブチル〕−２−（ω−グアニジノ脂肪酸アミド）−２−ヒドロキシエタンアミドおよびその誘導体ならびにその製造法 |
| JPS58198455A (ja) * | 1982-05-17 | 1983-11-18 | Microbial Chem Res Found | （−）−１５−デオキシスパガリンおよびその製造法並びにその中間体 |
| ES2039213T3 (es) * | 1986-04-04 | 1993-09-16 | Microbial Chemistry Research Foundation | Procedimiento para producir nuevos compuestos relacionados con espergualina. |
| EP0467280B1 (en) * | 1990-07-20 | 1994-09-28 | Nippon Kayaku Kabushiki Kaisha | Novel spergualin-related compound and use thereof |
-
1990
- 1990-05-14 YU YU93690A patent/YU48230B/sh unknown
- 1990-05-21 TW TW083110203A patent/TW275620B/zh active
- 1990-05-21 TW TW079104099A patent/TW275619B/zh active
- 1990-05-22 AU AU55800/90A patent/AU626676B2/en not_active Ceased
- 1990-05-23 EP EP90305617A patent/EP0400889B1/en not_active Expired - Lifetime
- 1990-05-23 CA CA002017361A patent/CA2017361C/en not_active Expired - Lifetime
- 1990-05-23 ES ES90305617T patent/ES2062363T3/es not_active Expired - Lifetime
- 1990-05-23 DE DE69006105T patent/DE69006105T2/de not_active Expired - Fee Related
- 1990-05-28 CZ CS902613A patent/CZ261390A3/cs not_active IP Right Cessation
- 1990-05-28 HU HU903227A patent/HU207844B/hu not_active IP Right Cessation
- 1990-05-28 CN CN90103806A patent/CN1017621B/zh not_active Expired
- 1990-05-28 PL PL90285375A patent/PL163358B1/pl not_active IP Right Cessation
- 1990-05-28 AR AR90316949A patent/AR247877A1/es active
- 1990-05-28 KR KR1019900007699A patent/KR940005918B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR900018015A (ko) | 1990-12-20 |
| AU5580090A (en) | 1990-11-29 |
| EP0400889A1 (en) | 1990-12-05 |
| CN1017621B (zh) | 1992-07-29 |
| AR247877A1 (es) | 1995-04-28 |
| CZ283320B6 (cs) | 1998-02-18 |
| EP0400889B1 (en) | 1994-01-19 |
| TW275619B (cg-RX-API-DMAC7.html) | 1996-05-11 |
| HU207844B (en) | 1993-06-28 |
| AU626676B2 (en) | 1992-08-06 |
| CA2017361A1 (en) | 1990-11-29 |
| TW275620B (cg-RX-API-DMAC7.html) | 1996-05-11 |
| YU48230B (sh) | 1997-08-22 |
| DE69006105D1 (de) | 1994-03-03 |
| CN1047670A (zh) | 1990-12-12 |
| KR940005918B1 (ko) | 1994-06-24 |
| CA2017361C (en) | 1996-09-03 |
| ES2062363T3 (es) | 1994-12-16 |
| HU903227D0 (en) | 1990-10-28 |
| CZ261390A3 (cs) | 1998-02-18 |
| HUT54633A (en) | 1991-03-28 |
| PL163358B1 (pl) | 1994-03-31 |
| PL285375A1 (en) | 1991-08-12 |
| YU93690A (sh) | 1992-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69921192T2 (de) | Ethanolate des azithromycin, herstllungsverfahren und deren pharmazeutische zusammenstellungen | |
| AT392472B (de) | Verfahren zur herstellung eines stabilen kristallinen di- oder trihydrats der 7beta- ((z)-2-(2-aminothiazol-4-yl)-4-carboxybut-2- enoylamino)-3-cephem-4-carbonsaeure | |
| DE69322087T2 (de) | Neues kristall von heterozyclischen bis(phosphonsäure) monohydrat-derivat | |
| DD271705A5 (de) | Verfahren zum herstellen von azithromycin-dihydrat | |
| DE3784260T2 (de) | Verbesserte spruehgetrocknete lactose und verfahren zu deren herstellung. | |
| DE69610374T2 (de) | Verfahren zur Herstellung einer Kristallinen Sonderform von Zilpaterolhydrochlorid, und benutze Zwischenprodukte | |
| DE69202483T2 (de) | Stabil fest 2-octynyladenozin und Verfahren zu ihrer Herstellung. | |
| DE69423459T2 (de) | Dihydrat des N-(4-Amino-6,7-dimethoxychinazol-2-yl)-N-methyl-N'-(tetrahydrofuroyl-2)-propylendiamin Hydrochlorids(=Alfuzosin Hydrochlorid Dihydrat) und ein Verfahren zur Herstellung | |
| DE60006814T2 (de) | Dinucleotid-kristalle | |
| DE69510999T2 (de) | Terazosinmonohydrochlorid und Verfahren und Zwischenprodukte für seine Herstellung | |
| DD208613A5 (de) | Verfahren zur herstellung neuer kristallmodifikationen des (+)-catechinmonohydrats und des (+)-catechinanhydrats | |
| DE69833220T2 (de) | Kristallines amrubicin-hydrochlorid | |
| DE69016683T2 (de) | Natrium-N-acetylneuraminat-trihydrat und Verfahren zu dessen Herstellung. | |
| AT398204B (de) | Mono-(2-ammonium-2-hydroxymethyl-1,3-propandiol (2r,cis)-1,2-epoxypropylphosphonat und verfahren zu dessen herstellung sowie pharmazeutische zusammensetzungen | |
| DE60131416T2 (de) | Chirale fluochinolon-argininsalzformen | |
| DE69013305T2 (de) | Stabile form von cephradin, verfahren zu dessen herstellung und darin verwendete zwischenprodukte. | |
| DE3443065C2 (cg-RX-API-DMAC7.html) | ||
| DE2718730A1 (de) | Cephalosporin-antibiotika | |
| DE69211220T2 (de) | Pharmazeutische Verbindungen | |
| DE69006105T2 (de) | Kristallines Deoxyspergualin und Verfahren zu seiner Herstellung. | |
| DE3141030C2 (cg-RX-API-DMAC7.html) | ||
| DE69614936T2 (de) | d4T polymorphe Form I Verfahren | |
| DE69917282T2 (de) | Verfahren zur herstellung von zofenopril-calciumsalz | |
| DE69107098T2 (de) | 2'-Deoxy-2'-Methylidenecytidin-dihydrat, Verfahren zu ihrer Herstellung und Mischmaterial. | |
| DE2019308C3 (de) | Kristallines Cytidin-5'-diphosphatcholinmonohydrat und Verfahren zu seiner Herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: TAKARA HOLDINGS INC., KYOTO, JP Owner name: NIPPON KAYAKU K.K., TOKIO/TOKYO, JP |
|
| 8339 | Ceased/non-payment of the annual fee |